









Markets
/
Stocks
/
nasdaq-aiff
/

Firefly Neuroscience Inc

AIFF

View Detailed Chart

3.020USD

-0.010-0.33%

Close 07/07, 16:00（ET）Quotes delayed by 15 min

35.27MMarket Cap

LossP/E TTM



Firefly Neuroscience Inc

3.020

-0.010-0.33%

Company

Intraday

30m

Today

-0.33%

5 Days

+6.71%

1 Month

-10.39%

6 Months

+16.60%

Year to Date

+13.96%

1 Year

-44.99%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(7)

Neutral(3)

Buy(3)

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.049

Neutral

RSI(14)

48.641

Neutral

STOCH(KDJ)(9,3,3)

49.894

Buy

ATR(14)

0.262

High Vlolatility

CCI(14)

46.967

Neutral

Williams %R

70.093

Sell

TRIX(12,20)

-0.386

Sell

StochRSI(14)

60.352

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

3.012

Buy

MA10

2.940

Buy

MA20

3.025

Sell

MA50

3.141

Sell

MA100

4.012

Sell

MA200

3.600

Sell

News

ChatGPT Aids Diagnoses Rare Illness; Microsoft Hits AI Healthcare Milestone—Is AI Healthcare the Next Big Trend?

TradingKey - AI in healthcare re-entered the public spotlight, sparking widespread discussion, following a retweet by OpenAI co-founder Greg Brockman.

TradingKey16 hours ago

Company

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).

Ticker SymbolAIFF

CompanyFirefly Neuroscience Inc

CEOMr. Greg Lipschitz

Websitehttps://fireflyneuro.com/